Menu

Scalp Microbiome Linked to Dandruff Severity

Researchers identify differences in the composition of microbial species living on the scalps of people with different levels of dandruff.

May 12, 2016
Catherine Offord

WIKIMEDIA, HMOCHOA95Dandruff affects about half of the postpubescent population, and previous studies have suggested that microbes living on the scalp are the main cause. Now, a team led by researchers at Shanghai Jiao Tong University, China, have found that the severity of dandruff is linked to the composition of those microbes—in particular, bacteria—offering potential opportunities for treatment. The findings were published today (May 12) in Scientific Reports.

Researchers have suggested a number of factors to explain the presence of dandruff, including the quantity of a natural oily substance called sebum secreted through a person’s skin, and the action of scalp-living Malassezia fungi that have been implicated in various forms of dermatitis. But sequencing the bacteria and fungi living in 174 scalp samples from 59 people with slight to moderate dandruff, the Shanghai researchers found that, in fact, the composition of bacterial species was more strongly associated with dandruff severity than the composition of fungal species. Some species, such as Staphylococcus, were linked to increased severity of dandruff, while others, such as Propionibacterium, showed some capacity to inhibit dandruff-associated bacteria.

Based on the findings, the authors suggest that controlling the composition of microbes living on a person’s scalp could provide potential treatment solutions for the condition. “The relationship between the severity of dandruff and the bacteria suggested that adjusting the equilibrium of the bacteria, particularly by increasing the Propionibacterium and decreasing the Staphylococcus on the scalp, might be a novel way to lessen the severity of dandruff,” they wrote in their paper.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

Cell culture made easy with new 24-channel pipetting heads for VIAFLO 96/384
Cell culture made easy with new 24-channel pipetting heads for VIAFLO 96/384
INTEGRA has responded to customers’ requests and developed two new 24-channel pipetting heads, extending the capabilities of its popular VIAFLO 96/384.
Horizon Discovery extends CRISPR Screening Service to primary human T cells
Horizon Discovery extends CRISPR Screening Service to primary human T cells
Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Company”), a global leader in gene editing and gene modulation technologies, today announced the extension of its CRISPR Screening Service to includeex vivoT lymphocytes. The service extension meets the requirements of immunology-based research in drug discovery,enabling new gene targets to be identified in biologically and potentially therapeutically relevant settings.
pIC50: The Advantages of Thinking Logarithmically
pIC50: The Advantages of Thinking Logarithmically
Watch this webinar from Collaborative Drug Discovery to learn about how using pIC50 helps you get a better sense of the relative potencies, calculate the correct mean of multiple values, and select better sampling doses.
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.